Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1140 of 6351
-
New combo therapy shows promise for lymphoma in seniors
Disease control CompletedRATIONALE: Drugs used in chemotherapy, such as doxorubicin, vincristine, and cyclophosphamide, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Steroid therapy, such as prednisone, may be effective in treati…
Phase 2 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Liver-Directed chemo may shrink tumors enough for surgery in colorectal cancer
Disease control OngoingRATIONALE: Hepatic arterial infusion uses a catheter to carry tumor-killing substances directly into the liver. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving floxuridine a…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Promising combo tackles Hard-to-Treat lymphoma
Disease control CompletedRATIONALE: Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as cyclophosphamide, vincristine, and prednisone, work in different ways to stop the growth of cancer cells, either by killing the ce…
Phase 2 • Sponsor: NCIC Clinical Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for kids with wilms tumor: tailored treatment aims to stop relapse
Disease control CompletedThis phase III trial is studying how well combination chemotherapy with or without radiation therapy works in treating young patients with newly diagnosed stage III or stage IV Wilms' tumor. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, eith…
Phase 3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could a Two-Drug HIV combo protect babies without extra side effects?
Prevention CompletedIn the pre-partum phase the use of antiretroviral therapy for the mother during the last trimester of pregnancy is mandatory. The use of HAART during pregnancy, usually two nucleosides analogues and a protease inhibitor exposes the mother and the child to cumulate toxicities rela…
Phase 2/3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Prevention
Last updated Jun 27, 2026 12:04 UTC
-
Can a puff of insulin replace a needle for diabetes?
Disease control CompletedThis study is to determine if inhaled insulin is effective in treating type 2 diabetes mellitus.
Phase 4 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a modified virus shrink Hard-to-Treat melanoma tumors?
Disease control CompletedThe purpose of this research study is to find out whether JX-594 (Pexa-Vec) is safe and effective for treating surgically unresectable malignant melanoma.
Phase 1/2 • Sponsor: Jennerex Biotherapeutics • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can a computer program tame sickle cell pain crises?
Symptom relief CompletedSickle cell disease (SCD) is a blood disorder that is characterized by intense, painful episodes known as sickle cell crises. This study will evaluate the effectiveness of PAINRelieveIt, a three-part computer-based pain management tool, in treating adults with SCD.
Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Can a plasma beam stop anal lesions from becoming cancer?
Disease control CompletedThe purpose of this study is to assess if argon plasma coagulation (APC) is a safe and well tolerated treatment method for anal intraepithelial neoplasia (AIN) grade 2/3 in HIV-positive men having sex with men (MSM).
Phase 2 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
ALS drug edaravone shows promise in slowing disease progression
Disease control CompletedThis is a long-term, double-blind, placebo-controlled study of MCI-186 to treat ALS. This study is the long-term extension of Study NCT00330681; Study NCT00330681 is a Phase 3, randomized, double-blind, placebo control, parallel assignment, 24-week study in the treatment of ALS. …
Phase 3 • Sponsor: Shionogi • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New hope for kids with resistant neuroblastoma: targeted radiation plus chemo tested
Disease control CompletedRATIONALE: Radioactive drugs, such as iodine I 131 metaiodobenzylguanidine (MIGB), may carry radiation directly to tumor cells and not harm normal cells. Drugs used in chemotherapy, such as irinotecan and vincristine, work in different ways to stop the growth of tumor cells, eith…
Phase 1 • Sponsor: New Approaches to Neuroblastoma Therapy Consortium • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can a puff of insulin replace a daily shot for diabetes?
Disease control CompletedTo compare efficacy and safety of Exubera® vs Lantus® in patients with type 2 diabetes mellitus.
Phase 4 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a second drug boost the cure rate for a common sexually transmitted infection?
Disease control CompletedThis study will look at the safety, effectiveness, and tolerability of combination medications for the initial treatment of non-gonococcal urethritis (NGU). NGU is inflammation of the tube that carries urine from the bladder. NGU is caused by bacteria that may be passed from pers…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New hope for myeloma patients with chromosome abnormalities?
Disease control OngoingWith this study - Total Therapy IIIB - researchers are extending the findings of Total Therapy III based what they have learned from the first two studies (Total Therapy I and II), with new research strategies designed to explore why chromosome abnormalities found in persons with…
Phase 3 • Sponsor: University of Arkansas • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New drug cocktail shows promise for myeloma patients
Disease control OngoingThe purpose of this study is to determine the safety and efficacy of the bortezomib, lenalidomide and dexamethasone combination in patients with newly diagnosed multiple myeloma. We are looking for the highest dose of the combination that can be given safely and see how well it w…
Phase 1/2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Can adding a second steroid improve survival in severe sepsis?
Disease control CancelledThe purpose of this study is to determine if the combination of hydrocortisone plus fludrocortisone is more efficacious than hydrocortisone alone in treating adrenal insufficiency in severe sepsis.
Phase 4 • Sponsor: CAMC Health System • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a year of aripiprazole be safe for kids with autism?
Disease control CompletedThis study will provide long-term safety data for patients who are taking aripiprazole for up to 1 year. Most patients enrolled in this study will have participated in a short-term study with aripiprazole (CN138-178 \[NCT00332241\] or CN138-179 \[NCT00337571\]).
Phase 3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can four group sessions teach safer habits to injection drug users?
Prevention CompletedTo conduct a randomized clinical trial (RCT) of a community-friendly behavioral intervention designed to reduce HIV risk behavior among injection drug users (IDUs) in drug treatment by comparing risk-behavior outcomes of four weekly intervention sessions with a time-and-attention…
Sponsor: University of Connecticut • Aim: Prevention
Last updated Sep 04, 2026 00:00 UTC
-
Mapping the Brain's electrical signals to improve surgical precision
Knowledge-focused Recruiting nowThe NIH grant has funded the development of a physiological brain atlas registry that will allow us to significantly improve the data collectioin and use of physiological data into a normalized brain volume. This initially was used to improve DBS implants for Parkinson's Disease,…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
New hope for haemophilia a patients: immune tolerance induction may eliminate clotting factor blockers
Disease control Recruiting nowThis research program is initiated to evaluate and document data on the success of ITI in 300 haemophilia A patients with newly developed or already existing FVIII-inhibitors (also patients who might potentially have failed in earlier ITIs), which will be treated with ITI - prefe…
Sponsor: Haemophilia Centre Rhine Main • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC